rs2659871
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_003737.4(DCHS1):c.3696G>A(p.Pro1232=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.398 in 1,613,602 control chromosomes in the GnomAD database, including 129,342 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.44 ( 15301 hom., cov: 33)
Exomes 𝑓: 0.39 ( 114041 hom. )
Consequence
DCHS1
NM_003737.4 synonymous
NM_003737.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.100
Genes affected
DCHS1 (HGNC:13681): (dachsous cadherin-related 1) This gene is a member of the cadherin superfamily whose members encode calcium-dependent cell-cell adhesion molecules. The encoded protein has a signal peptide, 27 cadherin repeat domains and a unique cytoplasmic region. This particular cadherin family member is expressed in fibroblasts but not in melanocytes or keratinocytes. The cell-cell adhesion of fibroblasts is thought to be necessary for wound healing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 11-6631387-C-T is Benign according to our data. Variant chr11-6631387-C-T is described in ClinVar as [Benign]. Clinvar id is 259138.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-6631387-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCHS1 | NM_003737.4 | c.3696G>A | p.Pro1232= | synonymous_variant | 8/21 | ENST00000299441.5 | NP_003728.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCHS1 | ENST00000299441.5 | c.3696G>A | p.Pro1232= | synonymous_variant | 8/21 | 1 | NM_003737.4 | ENSP00000299441 | P1 | |
ENST00000656961.1 | n.267C>T | non_coding_transcript_exon_variant | 2/3 | |||||||
ENST00000526633.1 | n.168C>T | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.441 AC: 66999AN: 151916Hom.: 15254 Cov.: 33
GnomAD3 genomes
AF:
AC:
66999
AN:
151916
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.409 AC: 102309AN: 250348Hom.: 21089 AF XY: 0.403 AC XY: 54579AN XY: 135316
GnomAD3 exomes
AF:
AC:
102309
AN:
250348
Hom.:
AF XY:
AC XY:
54579
AN XY:
135316
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.393 AC: 575044AN: 1461568Hom.: 114041 Cov.: 59 AF XY: 0.393 AC XY: 285487AN XY: 727070
GnomAD4 exome
AF:
AC:
575044
AN:
1461568
Hom.:
Cov.:
59
AF XY:
AC XY:
285487
AN XY:
727070
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.441 AC: 67095AN: 152034Hom.: 15301 Cov.: 33 AF XY: 0.439 AC XY: 32626AN XY: 74328
GnomAD4 genome
AF:
AC:
67095
AN:
152034
Hom.:
Cov.:
33
AF XY:
AC XY:
32626
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1440
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 06, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Van Maldergem syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at